Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Good discussion boys

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Oct 24, 2023 9:20pm

234 Views

Post# 35699334

RE:RE:RE:Good discussion boys

Let's be clear here, they now have 40% CR+IR optimized patient data on 33 patients. @ 450days. They can submit BTD as soon as they have the data FDA requested. Which they may have at this time.38% CR+IR Dara @450 days on the non optimized group of ~40 patients. Pretty good %s and significantly better than keytruda. Ruvdar has few side effects and is a monmo treatment.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”